Novel agents for anti-platelet therapy
Abstract Anti-platelet therapy plays an important role in the treatment of patients with thrombotic diseases.The most commonly used anti-platelet drugs, namely, aspirin, ticlopidine, and clopidogrel, are effective in the prevention and treatment of cardio-cerebrovascular diseases.Glycoprotein IIb/IIIa antagonists (e.g., abciximab, eptifibatide and